Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease.

Guo J, Ren W, Li A, Ding Y, Guo W, Su D, Hu C, Xu K, Chen H, Xu X, Yang T, Jia W.

Dig Dis Sci. 2013 Apr;58(4):1004-9. doi: 10.1007/s10620-012-2516-6. Epub 2013 Jan 18.

PMID:
23329013
2.

Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.

Zhang J, Li S, Li J, Han C, Wang Z, Li C, Wang X, Liu Z, Wen J, Zheng L.

Chin Med J (Engl). 2014;127(21):3771-6.

PMID:
25382334
3.

FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction.

Bravard A, Lefai E, Meugnier E, Pesenti S, Disse E, Vouillarmet J, Peretti N, Rabasa-Lhoret R, Laville M, Vidal H, Rieusset J.

Diabetes. 2011 Jan;60(1):258-68. doi: 10.2337/db10-0281. Epub 2010 Oct 13.

4.

Early hypothalamic FTO overexpression in response to maternal obesity--potential contribution to postweaning hyperphagia.

Caruso V, Chen H, Morris MJ.

PLoS One. 2011;6(9):e25261. doi: 10.1371/journal.pone.0025261. Epub 2011 Sep 28.

5.

Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.

Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.

Eur J Gastroenterol Hepatol. 2008 Sep;20(9):843-54. doi: 10.1097/MEG.0b013e3282f9b203.

PMID:
18794597
6.

FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice.

Chen J, Zhou X, Wu W, Wang X, Wang Y.

J Physiol Biochem. 2015 Sep;71(3):405-13. doi: 10.1007/s13105-015-0420-1. Epub 2015 Jun 16.

PMID:
26078098
7.

Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease.

Collison KS, Maqbool Z, Saleh SM, Inglis A, Makhoul NJ, Bakheet R, Al-Johi M, Al-Rabiah R, Zaidi MZ, Al-Mohanna FA.

J Lipid Res. 2009 Aug;50(8):1521-37. doi: 10.1194/jlr.M800418-JLR200. Epub 2008 Nov 11.

8.

Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats.

Cui WX, Yang J, Chen XQ, Mao Q, Wei XL, Wen XD, Wang Q.

Am J Chin Med. 2013;41(3):487-502. doi: 10.1142/S0192415X13500353.

PMID:
23711137
9.

Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats.

Hussein O, Grosovski M, Lasri E, Svalb S, Ravid U, Assy N.

World J Gastroenterol. 2007 Jan 21;13(3):361-8.

10.

Effect of dietary fat to produce non-alcoholic fatty liver in the rat.

Ahmed U, Redgrave TG, Oates PS.

J Gastroenterol Hepatol. 2009 Aug;24(8):1463-71. doi: 10.1111/j.1440-1746.2009.05870.x.

PMID:
19702912
11.

Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.

Li S, Liao X, Meng F, Wang Y, Sun Z, Guo F, Li X, Meng M, Li Y, Sun C.

PLoS One. 2014 Jan 29;9(1):e86724. doi: 10.1371/journal.pone.0086724. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e92364.

12.

Accumulation of endoplasmic reticulum stress and lipogenesis in the liver through generational effects of high fat diets.

Li J, Huang J, Li JS, Chen H, Huang K, Zheng L.

J Hepatol. 2012 Apr;56(4):900-7. doi: 10.1016/j.jhep.2011.10.018. Epub 2011 Dec 13.

PMID:
22173165
13.

Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.

Ganji SH, Kukes GD, Lambrecht N, Kashyap ML, Kamanna VS.

Am J Physiol Gastrointest Liver Physiol. 2014 Feb 15;306(4):G320-7. doi: 10.1152/ajpgi.00181.2013. Epub 2013 Dec 19.

14.

Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation.

Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, Yeh MM, Nelson JE, Kowdley KV.

Hepatology. 2012 Apr;55(4):1103-11. doi: 10.1002/hep.24737. Epub 2012 Feb 15.

PMID:
21994008
15.

Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats.

Crescenzo R, Bianco F, Coppola P, Mazzoli A, Tussellino M, Carotenuto R, Liverini G, Iossa S.

Exp Physiol. 2014 Sep;99(9):1203-13. doi: 10.1113/expphysiol.2014.079632. Epub 2014 Jun 27.

16.

Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.

Hong XZ, Li LD, Wu LM.

Clin Exp Pharmacol Physiol. 2007 Jan-Feb;34(1-2):27-35.

PMID:
17201732
17.

A maternal "junk food" diet in pregnancy and lactation promotes nonalcoholic Fatty liver disease in rat offspring.

Bayol SA, Simbi BH, Fowkes RC, Stickland NC.

Endocrinology. 2010 Apr;151(4):1451-61. doi: 10.1210/en.2009-1192. Epub 2010 Mar 5.

18.

The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.

Lake AD, Novak P, Hardwick RN, Flores-Keown B, Zhao F, Klimecki WT, Cherrington NJ.

Toxicol Sci. 2014 Jan;137(1):26-35. doi: 10.1093/toxsci/kft230. Epub 2013 Oct 4.

19.

Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia.

Ng R, Wu H, Xiao H, Chen X, Willenbring H, Steer CJ, Song G.

Hepatology. 2014 Aug;60(2):554-64. doi: 10.1002/hep.27153. Epub 2014 May 19.

20.

Supplemental Content

Support Center